Millennium Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
Millennium Management's AUPH Position: Q3 2026 in Review
Millennium Management reduced its Aurinia Pharmaceuticals (AUPH) stake by 93% in Q3 2026, selling an estimated $3.63M and leaving 16,895 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #5406.
Millennium Management first reported a position in AUPH in Q1 2015 and has held it in 38 quarters since. The position peaked at $39.4M in Q4 2019. 277 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- Millennium Management held 16,895 shares of Aurinia Pharmaceuticals worth $274K as of Q3 2026.
- Millennium Management sold 227,407 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $3.63M.
- Aurinia Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5406 holding.
- Millennium Management first reported a position in Aurinia Pharmaceuticals in Q1 2015 and has held it in 38 quarters since.
- Millennium Management's Aurinia Pharmaceuticals position peaked at $39.4M in Q4 2019.
- 277 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.